Researchers are exploring the potential of artificial intelligence to accelerate biological research in laboratory settings. Some outlets report on new tools and technologies, such as GPT-Rosalind and NVIDIA BioNeMo, being introduced to support this effort, while others raise concerns about the risks to biosecurity. The effectiveness and limits of ai in biomedical research are being assessed, with one benchmark reportedly showing top ai scores achieving only 32% accuracy.